Improving Hypertension Medication Adherence for Older Adults
N/A
Completed
NCT05610059
| Condition | Aging, Medication Adherence, Hypertension |
|---|
| Phase | N/A |
|---|
| Sponsor | University of Arizona |
|---|
| Status | Completed |
|---|
| Enrollment | 200 participants |
|---|
| Interventions | Blood Pressure Technology System M, Blood Pressure Technology System E |
|---|
| Start date | Nov 2, 2022 |
|---|
| Completion date | Mar 14, 2025 |
|---|
| Results posted | Jul 31, 2026 |
|---|
Summary
This randomized controlled trial will assess the efficacy and scalability of a blood pressure technology system intervention. The investigators will enroll 224 older adults with hypertension to identify those who are nonadherent for one hypertension medication. The participants will be randomized to one of two groups (112 per group) to use the blood pressure system for 6-months. Both groups receive information about high blood pressure and medications. One group will also receive strategies that can be used to take medications and manage blood pressure. Both groups will complete a mid-assessment at 3-months and a post-assessment at 6-months.
Medication Adherence (MEMS Cap)
3 months, 6 months · Percentage
| Blood Pressure Technology System M | 67.29 ± 0.31 Percentage |
|---|
| Blood Pressure Technology System E | 53.72 ± 0.32 Percentage |
|---|
| Blood Pressure Technology System M | 63.47 ± 0.32 Percentage |
|---|
| Blood Pressure Technology System E | 53.56 ± 0.36 Percentage |
|---|
Medication Adherence Report Scale (MARS-5)
3 months, 6 months · Score on a scale
| Blood Pressure Technology System M | 23.62 ± 1.83 Score on a scale |
|---|
| Blood Pressure Technology System E | 24.00 ± 1.48 Score on a scale |
|---|
| Blood Pressure Technology System M | 23.94 ± 1.48 Score on a scale |
|---|
| Blood Pressure Technology System E | 23.66 ± 1.68 Score on a scale |
|---|
Open in BENITIONS
View on ClinicalTrials.gov
Other trials for this condition
All trials
This page summarises publicly available data from ClinicalTrials.gov. It is not medical advice and not investment advice. Always consult a qualified healthcare professional.